NCT07776873 clinical trial report covering Recombinant human prourokinase, Phase 3, endpoints, sponsor, geography, readout timing and development white spa

NCT07776691 clinical trial report covering Raludotatug deruxtecan, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07778316 clinical trial report covering TARLATAMAB-DLLE, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07777263 clinical trial report covering Goserelin Acetate, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07775339 clinical trial report covering Lerodalcibep, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07780656 clinical trial report covering SHR-1905, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07778836 clinical trial report covering Nomlabofusp, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07780669 clinical trial report covering SHR-1905, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07780643 clinical trial report covering SHR-1905, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07778693 clinical trial report covering MWN-109, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07779538 clinical trial report covering Trastuzumab, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07778667 clinical trial report covering Lucerastat, Phase 3, endpoints, sponsor, geography, readout timing and development white space.